HIGHBRIDGE CAPITAL MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$7,535,000
+256.9%
164,500
+210.6%
0.12%
+221.1%
Q4 2017$2,111,000
+221.8%
52,965
+223.0%
0.04%
+322.2%
Q3 2017$656,000
+80.7%
16,400
+95.2%
0.01%
+80.0%
Q2 2017$363,000
-87.2%
8,400
-96.0%
0.01%
-77.3%
Q4 2015$2,832,000
-29.4%
210,722
-26.3%
0.02%
-65.1%
Q3 2015$4,014,000
+623.2%
286,033
+775.4%
0.06%
+800.0%
Q2 2015$555,000
+19.1%
32,675
-41.9%
0.01%
+16.7%
Q4 2014$466,00056,2700.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders